Injectable Progestin-Only Contraception is Associated With Increased Levels of Pro-Inflammatory Cytokines in the Female Genital Tract.
about
Factors Driving the HIV Epidemic in Southern Africa.Genital Injury Signatures and Microbiome Alterations Associated With Depot Medroxyprogesterone Acetate Usage and Intravaginal Drying PracticesEffects of depot-medroxyprogesterone acetate on the immune microenvironment of the human cervix and endometrium: implications for HIV susceptibility.Immune Activation in the Female Genital Tract: Expression Profiles of Soluble Proteins in Women at High Risk for HIV Infection.5α-reduced progestogens ameliorate mood-related behavioral pathology, neurotoxicity, and microgliosis associated with exposure to HIV-1 Tat.Medroxyprogesterone acetate and levonorgestrel increase genital mucosal permeability and enhance susceptibility to genital herpes simplex virus type 2 infection.Genital-Systemic Chemokine Gradients and the Risk of HIV Acquisition in Women.The Interplay of Host Immunity, Environment and the Risk of Bacterial Vaginosis and Associated Reproductive Health Outcomes.Progesterone-based compounds affect immune responses and susceptibility to infections at diverse mucosal sites.Repeated administration of high-dose depot medroxyprogesterone acetate does not alter SHIVSF162p3 viral kinetics and tenofovir pharmacokinetics when delivered via intravaginal rings.A longitudinal analysis of the vaginal microbiota and vaginal immune mediators in women from sub-Saharan AfricaMisreporting of contraceptive hormone use in clinical research participants.Microbial Composition Predicts Genital Tract Inflammation and Persistent Bacterial Vaginosis in South African Adolescent Females.Hormonal Contraception and HIV-1 Acquisition: Biological Mechanisms.Exogenous oestrogen inhibits genital transmission of cell-associated HIV-1 in DMPA-treated humanized mice.Is a lower-dose, subcutaneous contraceptive injectable containing depot medroxyprogesterone acetate likely to impact women's risk of HIV?Role of Lactobacilli and Lactoferrin in the Mucosal Cervicovaginal Defense.
P2860
Q30387557-6F55AC36-CD34-4C0C-9833-45AA5313F1A7Q33553821-5197231E-3C1E-4B96-BBEC-409BCABB4B92Q33870365-6450E456-AEA3-472B-8F04-F384D80B30D5Q35905458-A5740891-6517-48E8-90D5-0591CA01122AQ36984167-28C79C42-F2C0-495D-9FDD-55A29B32DC25Q37280240-040C5A01-4C96-494C-BBF0-1C6364283B11Q37639078-240471F6-285A-44A3-9C29-EA8AD9117DB3Q38801593-4B750103-E089-4701-8B01-C31A64139A3AQ39237289-1D99F7BC-A33D-4BE2-8754-8C1E7320F72BQ40106510-0FEE659E-1218-40B8-A75E-C5F7F7C6BC7DQ41697082-48A1E89E-7DD4-47AA-B695-872D0A309B8BQ46010525-984BFED3-39EF-4720-85B2-350C8D90CB60Q46283712-64FDEFAE-F807-4E9E-94E8-FE2289EADE32Q47198102-976902B5-D08B-4DB2-A96C-5FF4483E7971Q47553314-93C56087-BC38-4129-B539-7ACE02C1DE06Q49838895-BEDED066-EA03-499C-9910-B908C3ACE7B5Q51739532-3C4D6995-D242-4771-B489-69AD3A7C391E
P2860
Injectable Progestin-Only Contraception is Associated With Increased Levels of Pro-Inflammatory Cytokines in the Female Genital Tract.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Injectable Progestin-Only Cont ...... s in the Female Genital Tract.
@en
type
label
Injectable Progestin-Only Cont ...... s in the Female Genital Tract.
@en
prefLabel
Injectable Progestin-Only Cont ...... s in the Female Genital Tract.
@en
P2093
P2860
P50
P356
P1476
Injectable Progestin-Only Cont ...... s in the Female Genital Tract.
@en
P2093
Charles Morrison
Jennifer Deese
Khatija Ahmed
Lut Van Damme
Saïd Abdellati
Tania Crucitti
William Miller
P2860
P304
P356
10.1111/AJI.12415
P577
2015-07-22T00:00:00Z